MetaADEDB 2.0 @ LMMD
Malignant transformation
(UMLS:C1608408)
UMLS ID:
C1608408
MeSH ID:
N/A
Synonym(s)
1.
Malignant transformation
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1GefitinibFAERS: 10US FAERS
2Ruxolitinib phosphateFAERS: 5US FAERS
3AfatinibFAERS: 3US FAERS
4LenalidomideFAERS: 3OFFSIDES
US FAERS
5Zoledronic AcidFAERS: 3US FAERS
6osimertinibFAERS: 3US FAERS
7DeferasiroxFAERS: 2US FAERS
8MethotrexateFAERS: 2US FAERS
9TamoxifenFAERS: 2US FAERS
10TemozolomideFAERS: 2US FAERS
11fludarabine phosphateFAERS: 2US FAERS
12BortezomibFAERS: 1US FAERS
13ClozapineFAERS: 1US FAERS
14FinasterideFAERS: 1US FAERS
15Imatinib MesylateFAERS: 1US FAERS
16MelphalanFAERS: 1US FAERS
17TacrolimusFAERS: 1US FAERS
18ThalidomideFAERS: 1US FAERS
19idelalisibFAERS: 1US FAERS
20nitisinoneFAERS: 1US FAERS
21venetoclaxFAERS: 1US FAERS
22OxymetholoneSIDER
23TamoxifenOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.